Abcellera Biologics Inc; Transgenic mice
Past New Requirement Updated
- Agency
-
Centers for Disease Control and Prevention
Department of Health and Human Services
- Solicitation expected
- Not on record
- Estimated value
- $700,000 to $1,500,000
- Set-aside
- No set-aside
Forecast facts
- Anticipated award
- NAICS code
- Not on record
- Points of contact
-
- Charmaine Mckenzie buo4@cdc.gov
Forecast details come from HHS's procurement forecast. Agencies' dates and values are estimates.
About this forecast
The Department of Health and Human Services Centers for Disease Control and Prevention (CDC) is forecasting a new requirement contract for transgenic mice through Abcellera Biologics Inc. The estimated contract award date is February 1, 2025, with the opportunity posted on December 10, 2025, indicating a future procurement for specialized biological research materials. This contract appears to be a continuation or renewal of an existing arrangement with Abcellera Biologics Inc, the incumbent contractor.
The point of contact for this opportunity is Charmaine Mckenzie from the National Center for Immunization and Respiratory Diseases (NCIRD), who can be reached at buo4@cdc.gov. While specific award values or precise quantities are not detailed in the forecast, the contract is not set aside for any particular small business category, suggesting it may be open to broader competitive bidding. The procurement is directly managed through the CDC, likely involving scientific research or medical development purposes related to immunization and respiratory disease studies.
Forecast text
Abcellera Biologics Inc; Transgenic mice
On GovTribe
Work this forecast
- Track it in your pipeline
- Find teaming partners
- Similar forecasts
- Ask GovTribe AI about this forecast